CID 42636651

1162264-07-4

Structural Information

Molecular Formula
C30H30FN5O3
SMILES
C[C@H](CN1CCOCC1)N2C3=C(C=C(C=C3)/C=C\4/C5=C(C=C(C=C5)F)OCC6=CC=CC=C64)N=C2NC(=O)N
InChI
InChI=1S/C30H30FN5O3/c1-19(17-35-10-12-38-13-11-35)36-27-9-6-20(15-26(27)33-30(36)34-29(32)37)14-25-23-5-3-2-4-21(23)18-39-28-16-22(31)7-8-24(25)28/h2-9,14-16,19H,10-13,17-18H2,1H3,(H3,32,33,34,37)/b25-14+/t19-/m1/s1
InChIKey
YPCLDHGBEKZGEB-RUDKWAFVSA-N
Compound name
[5-[(E)-(3-fluoro-6H-benzo[c][1]benzoxepin-11-ylidene)methyl]-1-[(2R)-1-morpholin-4-ylpropan-2-yl]benzimidazol-2-yl]urea
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

2
References

13
Patents

527.2333 Da
Monoisotopic Mass

3.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 528.24058 235.3
[M+Na]+ 550.22252 245.6
[M+NH4]+ 545.26712 239.4
[M+K]+ 566.19646 241.0
[M-H]- 526.22602 241.5
[M+Na-2H]- 548.20797 236.9
[M]+ 527.23275 238.4
[M]- 527.23385 238.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe